MLP_JOINBZ_ADC-PDF

In this issue, authors aim to provide technical guidance for scientists conducting various hybrid assays for ADC bioanalysis.
Also in this issue, the authors describe the validation of the three ligand binding bioanalytical assays utilizing highly specific reagents pivotal to current bioanalytical strategy to measure total antibody, active ADC and total ADC. Finally you can also read an article presenting bioanalytical strategies and considerations involved in developing successful ligand binding assays for ADC characterization from early discovery to late nonclinical stages of drug development.